Introduction
Hepatocellular carcinoma (HCC) is the fifth most common tumor and is one of the leading causes of cancer-related death in the world [1, 2] . The number of patients who are suffering from HCC is increasing in the United States and western nations [2, 3] .
Although surgical resection is the treatment of choice for HCC, several minimally invasive therapeutic techniques have been used as alternatives for treatment of HCC. In patients who were diagnosed with multifocal HCCs without vascular invasion or extrahepatic spread and a relatively preserved liver function, transarterial chemoembolization (TACE) is one of the most im-portant curative treatment options [4] [5] [6] . TACE using ethiodized oil (Lipiodol, Laboratoire Guerbet, Villepinte, France) mixed with anticancerous agents, has been widely performed. Lipiodol transports the anticancerous drug, and the arterial embolic material helps increase the effect of the anticancerous drug [7] .
Lipiodol is radiopaque on fluoroscopy to allow for visualization during the TACE procedure and reveals markedly high attenuation on CT images [8] .
After image-guided treatment of HCCs, CT and MRI play a crucial role in assessing the therapeutic efficacy, monitoring local tumor progression during follow-up, and detecting early viable tumor, including residual tumor [9] . Dynamic contrastenhanced CT findings of HCCs after TACE have been reported Objectives: To evaluate MRI findings of non-recurrent hepatocellular carcinomas with lipiodol uptake (LHCCs) treated with transarterial chemoembolization. Methods: 28 LHCCs were divided into two groups according to amount of lipiodol uptake and tumor size, retrospectively. According to amount of lipiodol uptake, HCCs were classified into group A with dense lipiodol uptake (more than 90%) and group B with partial lipiodol uptake (between 50% and 90%). For HCC size analysis, group I was defined by a longest diameter of less than 2 cm, and group II was defined by a longest diameter of greater than or equal to 2 cm. Results: In group A (n=16), eight LHCCs showed high signal intensity (SI) on T2weighted images (T2WI), ten LHCCs showed low SI on T1-weighted imaged (T1WI), six LHCCs showed decreased SI at higher b value of diffusion-weighted images (DWI). In group B (n=12), six LHCCs revealed high SI on T2WI, six LHCCs revealed low SI on T1WI, ten LHCCs decreased SI at higher b value of DWI. As compared with tumor size and SI, six of 12 LHCCs in group I and eight of 16 LHCCs in group II showed high SI on T2WI. Six LHCCs in group I and ten LHCCs in group II showed low SI on T1WI. All LHCCs were not enhanced. Conclusion: Signal intensities of LHCCs were variable, but more than half of LHCCs showed high SI on T2WI, low SI on T1WI, decreased SI at higher b value of DWI, regardless of lipiodol uptake or tumor size. (Ewha Med J 2016;39(4):110-117) Signal Intensities of Lipiodol Uptake in Hepatocellular Carcinomas on MRI widely, and they are familiar to radiologists.
Original Article
MRI findings of HCCs after TACE have not been widely reported, even though these might reveal variable signal intensity (SI) on T1 and T2-weighted images [8] . Therefore, it is difficult to interpret the SI of HCCs after TACE.
The purpose of this study was to evaluate the MRI findings of non-recurrent nodular HCCs with lipiodol uptake (LHCCs) treated with TACE, focusing especially on SI. Furthermore, we evaluated SI of MRIs for non-recurrent, LHCCs based on the amount of lipiodol and the size of the tumor.
Methods

Patients
Our Institutional Review Board (2014-10-007) approved this study and waived acquisition of informed consent due to the retrospective evaluation. 
Image evaluation
Two radiologists (one abdominal imaging specialist and one third year resident) retrospectively reviewed all MRI and CT images with consensus.
HCCs were analyzed according to the amount of lipiodol up- Group A was consisted of HCCs with dense lipiodol uptake (more than 90%) and group B with partial lipiodol uptake (between 50% and 90%). One HCC in group A had no T2WI, and one HCC in group B had no diffusion weighted images (b=0). HCC, hepatocellular carcinoma; T2WI, T2-weighted images; T1WI, T1-weighted images; DWI, diffusion-weighted images; GE in, in-phase gradient-echo images; GE out, out-of-phase gradient-echo images. Signal Intensities of Lipiodol Uptake in Hepatocellular Carcinomas on MRI take on precontrast CT images with bone window setting and were divided into two groups. Group A included 16 HCCs with dense uptake of lipiodol (more than 90%), and group B included 12 HCCs with partial uptake of lipiodol (between 50% and 90%) (Fig. 1) . The HCCs which uptook lipiodol less than 50% will be have fewer effect of lipiodol on MR SI, therefore we only included the HCCs showing dense (>90%) and partial (>50%) uptake of lipiodol on precontrast CT images.
For HCC size analysis, we divided the two groups of LHCCs according to the longest diameter of the tumor. Group I was defined by a diameter of less than 2 cm (n=12), and group II was defined by a diameter of greater than or equal to 2 cm (n=16). Tumor size ranged from 0.6 cm to 5.2 cm (average, 2.1 cm). Because the LHCCs of less than 2cm had similar tendency of the MR SI and also group II showed similar, we grouped LHCCs by the 2cm of the tumor diameter.
We retrospectively evaluated SI on the MRIs of LHCCs based on the amount of lipiodol uptake and tumor size. The SI of the HCCs on MRI was classified as high, iso, mixed (high and low), and low when compared to the normal liver parenchyma.
We evaluated whether LHCCs were enhanced on dynamic contrast-enhanced MRIs or not.
Results
Among the 16 dense LHCCs in group A, eight LHCCs (53%) showed high SI, and five LHCCs (33%) showed iso SI on T2WI. Ten LHCCs (63%) showed low SI, and three LHCCs Fig. 2) . Fig. 3 ).
According to the size of HCCs, all 12 LHCCs (100%) in group I revealed dense uptake of lipiodol, compared to five of 16 LHCCs (31%) in group II that revealed dense uptake of lipi-odol.
In group I, six LHCCs (50%) showed high SI, and four LHCCs (33%) showed iso SI on T2WI. On T1WI, six LHCCs (50%) showed low SI, and three LHCCs (25%) showed iso SI.
At b values of 0, 50, 400, and 800, iso SI was seen on DWI in eight, seven, six, and seven LHCCs, respectively. Six LHCCs (50%) showed decreased SI on DWI at higher b values of 400 and 800) ( Table 2 , Fig. 4) .
In Fig. 4 . MR images of a 73-year-old patient with a 0.7×0.6 cm-sized, small, hepatocellular carcinomas with dense lipiodol uptake in the hepatic segment 5. Hepatocellular carcinoma (arrows) shows dense uptake of lipiodol on precontrast computed tomography with bone window setting (A), low signal intensity on T2-weighted images (B) and T1-weighted images (C). Diffusion-weighted images reveals high signal intensity at a lower b factor (b=0) (D) and decreased signal intensity at a higher b factor (b=800) (E). Hepatocellular carcinoma with dense lipiodol uptake shows isointensity on in-phase gradient-echo images (F) and low signal intensity on out-of-phase gradient-echo images (G). Group I was defined by a longest diameter of less than 2 cm, and group II was defined by a longest diameter of greater than or equal to 2 cm. One HCC in group II had no T2-WI, and another HCC in group II had no diffusion weighted images with b=0 value. HCC, hepatocellular carcinoma; T2WI, T2-weighted images; T1WI, T1-weighted images; DWI, diffusion-weighted images; GE in, in-phase gradient-echo images; GE out, out-of-phase gradient-echo images.
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LHCCs (69%) revealed decreased SI on DWI at higher b values of 400 and 800 (Table 2) .
Among the total 28 LHCCs, 14 LHCCs (52%) revealed high SI, and seven LHCCs (26%) revealed iso SI on T2WI. Sixteen LHCCs (57%) revealed low SI, and five LHCCs (18%) revealed mixed SI on T1WI. At b values of 0, 50, 400, and 800 DWI showed high SI in 13, 15, 15 and 11 LHCCs, respectively. Sixteen LHCCs (57%) showed decreased SI at higher b values of 400 and 800. Fifteen LHCCs (54%) showed high SI on inphase GE, and 17 LHCCs (61%) showed low SI on out-ofphase GE.
Discussion
TACE is commonly performed to treat unresectable HCC and most secondary liver cancers. The purpose of TACE is to destroy the tumor and to deliver chemotherapeutic agents along with iodized oil and embolic material directly to the tumor. As a result, the tumor is exposed to a high concentration of chemotherapeutic agents for a prolonged period of time [10, 11] .
Therefore, TACE may cause acute ischemic damage to the HCC, and can cause coagulation necrosis, as the hepatic artery is the only artery that nourishes the HCC [12] .
Buckwalter et al. [13] reported that ethiodol (ethionized oil), a lipid-soluble iodate contrast medium used in lymphangiography, modified lymph node signaling by reducing T1 and increasing T2 relaxation time. Thus lymph nodes were not distinguished from subcutaneous fatty tissue. Lipiodol is a mixture of ethyl esters from iodurate fatty acids of plant origin and has the same effects on the HCCs in which it accumulates. De Santis et al. [14] reported that pure lipiodol showed a high SI on T1WI (higher than that of subcutaneous fatty tissue) and a low SI on T2WI (lower than that of subcutaneous fatty tissue). Therefore, lipiodol can show increased SI in both T1 and T2WI [14] .
De Santis et al. [14] reported that HCCs treated by TACE within one week showed high SI on T1WI, but HCCs treated by TACE after three months revealed variable SI on T1WI. A high concentration of lipiodol immediately after TACE led to high SI;
however, this concentration was too low to modify the intensity some period after TACE.
In our study of 28 LHCCs, only four showed high SI, but 16
LHCCs revealed low SI on T1WI. This may be because we obtained T1WIs with a fat suppression technique prior to dynamic contrast-enhanced imaging to detect enhancing lesions. Because lipiodol is a fatty acid, we hypothesized that it caused low SI on fat suppression T1WI.
In our cases of GE images, 15 LHCCs (54%) showed high SI on in-phase GE, and 17 LHCCs (61%) showed low SI on out- In viable tumors, intact membranes limit the mobility of water molecules, and the ADC is lower, which reflects restriction of diffusion [20] . On the other hand, cellular necrosis increases membrane permeability, allowing for increased motion of water molecules, which results in increased diffusion. After TACE, an increased ADC can be explained by treatment-induced necrosis and cell death [21] . In our study, 16 of 28 LHCCs (57%) showed decreased SI on DWI at high b values of 400 and 800. This suggests that coagulation necrosis and cell death may cause a decrease in SI. This finding could help differentiate viable tumor from treatmentinduced necrosis, even though uptake of lipiodol.
This study had several limitations. First, the number of patients and LHCCs was small. We ultimately chose 27 patients with 28 LHCCs. For more coherent results about the SI of LHCC, a study with a greater number of LHCCs will be needed.
Second, the time intervals between TACE and MRI and between
MRI and CT varied due to the retrospective nature of the study.
Third, this study was performed by retrospectively. There might be selection bias of patient groups. A prospective study with a large number of LHCCs in the multicenter is needed for further evaluation.
In conclusion, SI of LHCCs was variable on MRI. However, more than half of the LHCCs showed high SI on T2WI, low SI on T1WI, high SI on in-phase GE, low SI on out-of-phase GE, and decreased SI at higher DWI b values, regardless of the degree of lipiodol uptake or tumor size. No LHCCs were enhanced on dynamic contrast-enhanced MRI. These results can aid in interpreting MRI findings of LHCC and to differentiate them from recurrent HCCs. The radiologist should know these MRI findings to allow for proper interpretation and diagnosis.
